Publication: The Cross-Border Biotech Blog

First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Cross-Border Biotech Blog Relaunch

Bloom Burton & Co. is happy to announce that we will be picking up the torch of the Cross-Border Biotech Blog. The new, reinvigorated blog will feature commentary, data, analysis, case studies and interviews from well-known international healthcare executives ... [Published The Cross-Border Biotech Blog - Apr 02 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Monday Deal Review: March 31, 2014

Welcome to your Monday Biotech Deal Review for March 31, 2014! Hit the break to see our summary of the past weeks’ biotech news.   M&Eh Avidus Management Group Inc. ( TSX-V: AVD) announced that it has made the $400,000 payment required ... [Published The Cross-Border Biotech Blog - Mar 31 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 1 reports

Monday Deal Review: March 17, 2014

  Welcome to your Monday Biotech Deal Review for March 17, 2014, and happy St. Patrick’s day to the Irish (or Irish-for-a-day) among us! This past week saw Patheon complete their plan of arrangement with JLL/Delta Patheon Holdings, wherein JLL/Delta ... [Published The Cross-Border Biotech Blog - Mar 17 2014]
First reported Mar 10 2014 - Updated Mar 10 2014 - 1 reports

Monday Deal Review: March 10, 2014

  Welcome to your Monday Biotech Deal Review for March 10, 2014! M&Eh Patheon Inc. ( TSX: PTI ) (“Patheon”) announced that at a special meeting (the “Special Meeting”) of holders of its restricted voting shares (“Shareholders”), Shareholders ... [Published The Cross-Border Biotech Blog - Mar 10 2014]

More Content

All (8) | News (0) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Cross-Border Biotech Blog Relaunch [Published The Cross-Border Biotech Blog - Apr 02 2014]
Monday Deal Review: March 31, 2014 [Published The Cross-Border Biotech Blog - Mar 31 2014]
Monday Deal Review: March 17, 2014 [Published The Cross-Border Biotech Blog - Mar 17 2014]
Monday Deal Review: March 10, 2014 [Published The Cross-Border Biotech Blog - Mar 10 2014]
Monday Deal Review: February 24, 2014 [Published The Cross-Border Biotech Blog - Feb 25 2014]
Monday Deal Review: February 10, 2014 [Published The Cross-Border Biotech Blog - Feb 10 2014]
Monday Deal Review: February 3, 2014 [Published The Cross-Border Biotech Blog - Feb 03 2014]
Monday Deal Review: January 27, 2014 [Published The Cross-Border Biotech Blog - Jan 27 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Cross-Border Biotech Blog Relaunch [Published The Cross-Border Biotech Blog - Apr 02 2014]
Bloom Burton & Co. is happy to announce that we will be picking up the torch of the Cross-Border Biotech Blog. The new, reinvigorated blog will feature commentary, data, analysis, case studies and interviews from well-known international healthcare executives ...
Monday Deal Review: March 31, 2014 [Published The Cross-Border Biotech Blog - Mar 31 2014]
Welcome to your Monday Biotech Deal Review for March 31, 2014! Hit the break to see our summary of the past weeks’ biotech news.   M&Eh Avidus Management Group Inc. ( TSX-V: AVD) announced that it has made the $400,000 payment required ...
Monday Deal Review: March 17, 2014 [Published The Cross-Border Biotech Blog - Mar 17 2014]
  Welcome to your Monday Biotech Deal Review for March 17, 2014, and happy St. Patrick’s day to the Irish (or Irish-for-a-day) among us! This past week saw Patheon complete their plan of arrangement with JLL/Delta Patheon Holdings, wherein JLL/Delta ...
Monday Deal Review: March 10, 2014 [Published The Cross-Border Biotech Blog - Mar 10 2014]
  Welcome to your Monday Biotech Deal Review for March 10, 2014! M&Eh Patheon Inc. ( TSX: PTI ) (“Patheon”) announced that at a special meeting (the “Special Meeting”) of holders of its restricted voting shares (“Shareholders”), Shareholders ...
Monday Deal Review: February 24, 2014 [Published The Cross-Border Biotech Blog - Feb 25 2014]
  Welcome to your Monday Biotech Deal Review for February 24, 2014! M&Eh AtmanCo Inc. (“AtmanCo”) ( TSX-V: ATW ) announced that it has entered into an agreement to sell the assets of the cyberhealth division . The assets of the cyberhealth ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.